These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8743897)

  • 21. Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo.
    Zannis VI; Kan HY; Kritis A; Zanni EE; Kardassis D
    Curr Opin Lipidol; 2001 Apr; 12(2):181-207. PubMed ID: 11264990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
    Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
    Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism.
    Shachter NS
    Curr Opin Lipidol; 2001 Jun; 12(3):297-304. PubMed ID: 11353333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II.
    Fojo SS; Brewer HB
    J Intern Med; 1992 Jun; 231(6):669-77. PubMed ID: 1619390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endogenous hypertriglyceridemia].
    Kotake H; Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():63-8. PubMed ID: 11347144
    [No Abstract]   [Full Text] [Related]  

  • 28. Atherogenicity of triglyceride-rich lipoproteins.
    Krauss RM
    Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics of lipoprotein disorders.
    Breslow JL
    Circulation; 1984 Jun; 69(6):1190-4. PubMed ID: 6713620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic animals in lipoprotein research.
    Aalto-Setälä K
    Ann Med; 1992 Oct; 24(5):405-9. PubMed ID: 1418927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein lipase genetic variation and gender-specific ischemic cerebrovascular disease risk.
    Ordovas JM
    Nutr Rev; 2000 Oct; 58(10):315-8. PubMed ID: 11127970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler AJ; Brown WV; Lyons TJ; Garvey WT;
    Metabolism; 2004 Oct; 53(10):1296-304. PubMed ID: 15375785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.
    Utermann G; Hoppichler F; Dieplinger H; Seed M; Thompson G; Boerwinkle E
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4171-4. PubMed ID: 2524837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the apolipoprotein A-I-C-III gene complex.
    Karathanasis SK; Zannis VI; Breslow JL
    Methods Enzymol; 1986; 128():712-26. PubMed ID: 3014271
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipoproteins and heart disease. Transgenic mice models are helping in the search for new therapies.
    Breslow J
    Biotechnology (N Y); 1994 Apr; 12(4):365-7, 369-70. PubMed ID: 7764681
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
    Ando H; Nishimura Y; Nemoto T; Takamura T; Nagai Y; Kobayashi K
    Endocr J; 2001 Feb; 48(1):113-8. PubMed ID: 11403097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers.
    Vergnes L; Taniguchi T; Omori K; Zakin MM; Ochoa A
    Biochim Biophys Acta; 1997 Oct; 1348(3):299-310. PubMed ID: 9366246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility.
    Hegele RA; Breslow JL
    Genet Epidemiol; 1987; 4(3):163-84. PubMed ID: 2886398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein lipase: from gene to atherosclerosis.
    Li Y; He PP; Zhang DW; Zheng XL; Cayabyab FS; Yin WD; Tang CK
    Atherosclerosis; 2014 Dec; 237(2):597-608. PubMed ID: 25463094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.